arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

NANOVIRICIDES, INC.

NNVC
$1.27 ▼ -0.12 (-8.63%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

NANOVIRICIDES, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $25.6M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -75.6% ↗
FCF / Share $-0.39 ↗
Trailing P/E —
Price / Book 3.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-8.22M
↑ +13.2% —
FCF / Share Free cash flow per share
$-0.39
↑ +31.7% —
Long-Term Debt Long-term obligations
$4.73M
— 0.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
7
Cash Quality ↑
61

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 80 quarters